AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor

Neuro-Oncology

Volumn 13, Issue 2, 2011, Pages 184-194

  Liu, Juinn Lin ^a   Mao, Zhenyu ^a   Gallick, Gary E ^a,b   Yung, W K Alfred ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

AMPK; LKB1; mTOR; Nuclear export; PTEN

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; TUBERIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE ACTIVATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; AMP-ACTIVATED PROTEIN KINASES; BLOTTING, WESTERN; BREAST NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; METFORMIN; PROTEIN-SERINE-THREONINE KINASES; PTEN PHOSPHOHYDROLASE; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 79951827477     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq163     Document Type: Article

References (33)

1. Lian Z, Di Cristofano A. Class reunion: PTEN joins the nuclear crew. Oncogene. 2005;24(50):7394-7400. (Pubitemid 41637979)
2. Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol. 2000;156(5):1693-1700. (Pubitemid 30646707)
3. Lachyankar MB, Sultana N, Schonhoff CM, et al. A role for nuclear PTEN in neuronal differentiation. J Neurosci. 2000;20(4):1404-1413. (Pubitemid 30220420)
4. Perren A, Komminoth P, Saremaslani P, et al. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol. 2000;157(4):1097-1103.
5. Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, Eng C. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer. 2002;99(1):63-67. (Pubitemid 34273199)
6. Liu F, Wagner S, Campbell RB, Nickerson JA, Schiffer CA, Ross AH. PTEN enters the nucleus by diffusion. J Cell Biochem. 2005;96(2):221-234. (Pubitemid 41437856)
7. Gil A, Andres-Pons A, Fernandez E, et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell. 2006;17(9):4002-4013. (Pubitemid 44330883)
8. Chung JH, Ginn-Pease ME, Eng C. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res. 2005;65(10):4108- 4116. (Pubitemid 40775648)
9. Minaguchi T, Waite KA, Eng C. Nuclear localization of PTEN is regulated by Ca (2+) through a tyrosil phosphorylation-independent confor-mational modification in major vault protein. Cancer Res. 2006;66(24):11677-11682. (Pubitemid 46094179)
10. Wang X, Trotman LC, Koppie T, et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 2007;128(1):129-139. (Pubitemid 46048884)
11. Trotman LC, Wang X, Alimonti A, et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007;128(1):141-156. (Pubitemid 46048885)
12. Liu JL, Mao Z, Alonso M, Gallick GE, Fueyo J, Yung WK. Cell cycle-dependent nuclear export of PTEN tumor suppressor is regulated by the PI3K signaling cascade. Cancer Res. 2007;67(22):11054-11063. (Pubitemid 350145936)
13. Tachibana M, Shibakita M, Ohno S, et al. Expression and prognostic significance of PTEN product protein in patients with esophageal squa-mous cell carcinoma. Cancer. 2002;94(7):1955-1960. (Pubitemid 34270048)
14. Zhou XP, Loukola A, Salovaara R, et al. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol. 2002;161(2):439-447. (Pubitemid 36142153)
15. Bai Z, Ye Y, Chen D, et al. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis. APMIS. 2007;115(12):1383- 1390.
16. Fridberg M, Servin A, Anagnostaki L, et al. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lym-phoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma. 2007;48(11):2221-2232. (Pubitemid 350091065)
17. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577-590. (Pubitemid 37506046)
18. Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE, Yung WK. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol. 2005;25(14):6211-6224. (Pubitemid 40946569)
19. Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, Eng C. ATP modulates PTEN subcellular localization in multiple cancer cell lines. Hum Mol Genet. 2008;17(18):2877-2885.
20. Xie M, Zhang D, Dyck JR, et al. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA. 2006;103(46):17378-17383. (Pubitemid 44788977)
21. Høyer-Hansen M, Bastholm L, Szyniarowski P, et al. Control of macro-autophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell. 2007;25(2):193-205. (Pubitemid 46109606)
22. Jiang W, Zhu Z, Thompson HJ. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose. Mol Carcinog. 2008;47(8):616-628.
23. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem. 2005;280(32):29060-29066. (Pubitemid 41161355)
24. Guo D, Hildebrandt IJ, Prins RM, et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipo-genesis. Proc Natl Acad Sci USA. 2009;106(31):12932-12937.
25. Mehenni H, Lin-Marq N, Buchet-Poyau K, et al. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet. 2005;14(15):2209-2219. (Pubitemid 41418020)
26. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol. 2000;20(14):5010-5018. (Pubitemid 30431555)
27. Torres J, Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem. 2001;276(2):993-998. (Pubitemid 32096519)
28. Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites. FEBS Lett. 2002;528(1-3):145-153. (Pubitemid 35258015)
29. Denning G, Jean-Joseph B, Prince C, Durden DL, Vogt PK. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene. 2007;26(27):3930-3940. (Pubitemid 46884301)
30. Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214-226. (Pubitemid 351626684)
31. Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007;67(22):10804-10812. (Pubitemid 350145909)
32. Song MS, Salmena L, Carracedo A, et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature. 2008;455(7214):813-817.
33. Fouladkou F, Landry T, Kawabe H, et al. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci USA. 2008;105(25):8585-8590. (Pubitemid 351987724)